Want to see IN:LAXMIDENTL full AI Analyst Report?
Top Page
Laxmi Dental Ltd.
(LAXMIDENTL)
Select Model
Select Model
Rating:56Neutral
Price Target:
₹198.00
▲(1.49% Upside)
Action:N/A
Date:07/01/26
The score is held back primarily by the sharp deterioration in operating and free cash flow and by margin compression despite solid revenue growth. Technicals are mixed (supportive vs 50/100-day but still below the 200-day), and valuation is a notable headwind given the high P/E and no dividend yield data.
Positive Factors
Revenue Growth
Strong year-over-year revenue growth indicates continued demand for the company’s dental products and supports its market presence across clinics, laboratories, and distributors. If maintained, this top-line momentum can provide a durable base for rebuilding profitability and funding future expansion.
Negative Factors
Cash Flow Deterioration
The swing to negative operating and free cash flow shows that reported earnings are not currently converting into cash. Continued cash consumption could constrain internal funding, increase reliance on balance-sheet resources, and make expansion or working-capital needs harder to support.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong year-over-year revenue growth indicates continued demand for the company’s dental products and supports its market presence across clinics, laboratories, and distributors. If maintained, this top-line momentum can provide a durable base for rebuilding profitability and funding future expansion.
Read all positive factors
Laxmi Dental Ltd. (LAXMIDENTL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹10.57B
Dividend YieldN/A
Average Volume (3M)5.85K
Price to Earnings (P/E)34.1
Beta (1Y)1.41
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees2,163
SectorGeneral
Sector StrengthN/A
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)5.65
Shares Outstanding55,029,420
10 Day Avg. Volume3,928
30 Day Avg. Volume5,851
Financial Highlights & Ratios
PEG Ratio-2.56
Price to Book (P/B)4.01
Price to Sales (P/S)3.51
P/FCF Ratio-41.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)10.5
Revenue Forecast (FY)₹3.29B
Laxmi Dental Ltd. Business Overview & Revenue Model
Company Description
Laxmi Dental Limited operates as a global manufacturer and supplier of diverse dental products, serving markets across India, the United States, the United Kingdom, and beyond. Its comprehensive portfolio includes personalized crowns, bridges, tra...
How the Company Makes Money
Laxmi Dental Ltd. generates revenue primarily through the sale of dental materials and dental-related products to customers such as dental clinics, dental laboratories, and distributors. Key revenue streams include: (1) product sales where revenue...
Laxmi Dental Ltd. Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
88
Very Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.86B | 2.78B | 2.37B | 1.94B | 1.59B | 1.29B |
| Gross Profit | 1.11B | 776.94M | 734.47M | 1.49B | 345.70M | 220.26M |
| EBITDA | 482.39M | 434.00M | 522.20M | 254.15M | 108.27M | 63.84M |
| Net Income | 308.88M | 289.78M | 317.71M | 247.78M | -39.73M | -183.65M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 2.94B | 2.86B | 1.35B | 965.38M | 1.03B |
| Cash, Cash Equivalents and Short-Term Investments | 222.33M | 1.04B | 1.09B | 9.73M | 15.80M | 14.33M |
| Total Debt | 0.00 | 130.09M | 195.12M | 497.77M | 387.11M | 386.82M |
| Total Liabilities | -2.44B | 498.60M | 774.87M | 899.51M | 770.56M | 798.04M |
| Stockholders Equity | 2.44B | 2.43B | 2.09B | 424.65M | 177.92M | 210.65M |
Cash Flow | ||||||
| Free Cash Flow | -257.82M | -233.68M | 277.54M | -66.06M | 44.58M | -116.06M |
| Operating Cash Flow | -200.07M | -49.97M | 438.32M | 81.51M | 144.41M | -19.95M |
| Investing Cash Flow | -650.79M | -795.84M | -292.42M | -108.05M | -93.94M | 30.42M |
| Financing Cash Flow | -146.27M | -177.52M | 1.11B | -26.63M | -14.51M | -40.27M |
Laxmi Dental Ltd. Technical Analysis
Negative
195.10
Price Trends
203.68
Negative
212.93
Negative
212.37
Negative
Market Momentum
-2.31
Negative
40.81
Neutral
28.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:LAXMIDENTL, the sentiment is Negative. The current price of 195.1 is below the 20-day moving average (MA) of 197.03, below the 50-day MA of 203.68, and below the 200-day MA of 212.37, indicating a bearish trend. The MACD of -2.31 indicates Negative momentum. The RSI at 40.81 is Neutral, neither overbought nor oversold. The STOCH value of 28.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:LAXMIDENTL.
Laxmi Dental Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ₹166.33B | 52.90 | ― | 0.21% | 18.31% | -12.86% | |
62 Neutral | ₹10.18B | 23.68 | ― | ― | 11.31% | 144.96% | |
62 Neutral | ₹12.64B | 26.70 | ― | 1.62% | 18.08% | -0.78% | |
56 Neutral | ₹10.57B | 34.07 | ― | ― | ― | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ₹11.07B | 27.64 | ― | 0.41% | -12.75% | ― | |
47 Neutral | ₹17.56B | 158.06 | ― | 0.42% | 10.63% | -59.63% |
* General Sector Average
IN:LAXMIDENTL
Laxmi Dental Ltd.
192.15
-133.40
-40.98%
IN:BOROSCI
Borosil Scientific Limited
114.45
-13.20
-10.34%
IN:GPTHEALTH
GPT Healthcare Limited
154.05
9.53
6.60%
IN:POLYMED
Poly Medicure Limited
1,641.00
-300.27
-15.47%
IN:TARSONS
Tarsons Products Limited
330.10
25.45
8.35%
IN:THEMISMED
Themis Medicare Limited
120.20
-13.96
-10.41%
Laxmi Dental Ltd. Corporate Events
Laxmi Dental secures exchange nod for ESOP share listing
Aug 31, 2026
Laxmi Dental Limited has obtained approvals from both the National Stock Exchange of India and BSE for the listing and trading of an additional 59,360 equity shares issued under its Laxmi Dental Employee Stock Option Scheme 2024. The new shares, c...
Laxmi Dental clears Q1 FY27 results, ESOP allotment and Palghar land deal
Aug 11, 2026
Laxmi Dental Ltd. reported its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following a board meeting held on August 11, 2026, in line with SEBI disclosure norms. The board also approved several corp...
Laxmi Dental Publishes Q1 FY27 Investor Presentation on Unaudited Results
Aug 11, 2026
Laxmi Dental Limited has released an investor presentation tied to its Q1 FY27 earnings conference call, covering the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The presentation, made available in ...
Laxmi Dental Schedules SEBI-Compliant Investor Meet on July 3
Jun 30, 2026
Laxmi Dental Limited, formerly known as Laxmi Dental Export Private Limited, operates in the dental products and services sector and is listed on both BSE and NSE under the symbol LAXMIDENTL, providing solutions to domestic and institutional custo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.